SBIO.US ALPS Medical Breakthroughs ETF

- USD
No recent price
Total assets
181M
Expense ratio
0.50%
Dividend yield
-
1-year return
+17.61%
Holdings
100
Since
2014

Fund data as reported by the issuer, updated Nov 17, 2026. Total assets are in the fund's base currency.

What does SBIO.US invest in?

  • Mostly US stocks (89.8%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (90.8%)
  • Top 3 holdings: 12.1% of the fund

Asset allocation

  • US stocks 89.8%
  • Non-US stocks 7.6%

Top holdings

All holdings, sectors and regions

ALPS Medical Breakthroughs ETF performance

Sharpe ratio 1.01
This year
+5.37%
1 year
+17.61%
3 years
+31.32%
5 years
+4.12%

Volatility 25.5% over 1 year and 28.4% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

SBIO.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About ALPS Medical Breakthroughs ETF

The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

Full fund profile